NASDAQ
Nasdaq's Lifeline: NeuroOne Medical Technologies Secures 180-Day Extension Amidst Delisting Fears
November 5, 2025 – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has been granted a crucial 180-day extension by Nasdaq, providing a temporary reprieve from potential delisting. This development, announced today, comes as the medical device company grapples with its common stock trading below the exchange's mandated minimum bid price